Repaglinide Rivopharm 0.5 mg
Repaglinide Rivopharm 0.5 mg is a medicine authorised by Swissmedic under authorisation number 61234. The authorisation holder is Rivopharm SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 May 2011 and the authorisation is valid without a time limit. ATC code A10BX02 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 61234 |
|---|---|
| Name | Repaglinide Rivopharm 0.5 mg |
| Full name | Repaglinide Rivopharm 0.5 mg, compresse |
| Authorisation holder | Rivopharm SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BX02 |
| First authorisation | 24 May 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Repaglinide Rivopharm 0.5 mg, compresse | B | 24 May 2011 |
| 2 | Repaglinide Rivopharm 1 mg, compresse | B | 24 May 2011 |
| 3 | Repaglinide Rivopharm 2 mg, compresse | B | 24 May 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 16 | 90 | Tablette(n) | A10BX02 | 07.06.2. | B |
| 17 | 90 | Tablette(n) | A10BX02 | 07.06.2. | B |
| 18 | 90 | Tablette(n) | A10BX02 | 07.06.2. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Repaglinide Rivopharm 0.5 mg authorised in Switzerland?
Yes. Repaglinide Rivopharm 0.5 mg is authorised by Swissmedic under authorisation number 61234, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Repaglinide Rivopharm 0.5 mg have?
Repaglinide Rivopharm 0.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Repaglinide Rivopharm 0.5 mg?
The authorisation holder is Rivopharm SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.